Bitter Taste Receptors for Asthma Therapeutics

Clinical management of asthma and chronic obstructive pulmonary disease (COPD) has primarily relied on the use of beta 2 adrenergic receptor agonists (bronchodilators) and corticosteroids, and more recently, monoclonal antibody therapies (biologics) targeting specific cytokines and their functions....

Descripción completa

Detalles Bibliográficos
Autores principales: Nayak, Ajay P., Shah, Sushrut D., Michael, James V., Deshpande, Deepak A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Physiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647873/
https://www.ncbi.nlm.nih.gov/pubmed/31379597
http://dx.doi.org/10.3389/fphys.2019.00884

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647873/
https://www.ncbi.nlm.nih.gov/pubmed/31379597
http://dx.doi.org/10.3389/fphys.2019.00884

Ejemplares similares